AR012480A1 - Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona - Google Patents

Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona

Info

Publication number
AR012480A1
AR012480A1 ARP980101819A ARP980101819A AR012480A1 AR 012480 A1 AR012480 A1 AR 012480A1 AR P980101819 A ARP980101819 A AR P980101819A AR P980101819 A ARP980101819 A AR P980101819A AR 012480 A1 AR012480 A1 AR 012480A1
Authority
AR
Argentina
Prior art keywords
tibolone
vehicle
pharmaceutical
units
dedosis
Prior art date
Application number
ARP980101819A
Other languages
English (en)
Spanish (es)
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of AR012480A1 publication Critical patent/AR012480A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP980101819A 1997-04-22 1998-04-21 Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona AR012480A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201180 1997-04-22

Publications (1)

Publication Number Publication Date
AR012480A1 true AR012480A1 (es) 2000-10-18

Family

ID=8228228

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101819A AR012480A1 (es) 1997-04-22 1998-04-21 Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona

Country Status (25)

Country Link
US (6) US6399594B2 (2)
EP (1) EP0975348B1 (2)
JP (1) JPH10316573A (2)
KR (1) KR100580855B1 (2)
CN (2) CN1146424C (2)
AR (1) AR012480A1 (2)
AT (1) ATE281836T1 (2)
AU (1) AU742037B2 (2)
BR (1) BR9809268A (2)
CA (1) CA2288070A1 (2)
DE (1) DE69827484T2 (2)
DK (1) DK0975348T3 (2)
ES (1) ES2232949T3 (2)
HU (1) HUP0001780A3 (2)
ID (1) ID22763A (2)
IL (1) IL123984A (2)
NO (1) NO995127L (2)
NZ (1) NZ338028A (2)
PL (1) PL190227B1 (2)
PT (1) PT975348E (2)
RU (1) RU2207133C2 (2)
TR (1) TR199902530T2 (2)
TW (1) TW570798B (2)
WO (1) WO1998047517A1 (2)
ZA (1) ZA983169B (2)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284569B6 (sk) * 1998-10-16 2005-06-02 Akzo Nobel N.V. Vysoko čistá zlúčenina (7alfa, 17alfa)-17-hydroxy-7-metyl-19-nor- 17-pregn-5(10)-én-20-ín-3-ón, spôsob jej prípravy a farmaceutická dávková jednotka s jej obsahom
WO2000051570A1 (fr) * 1999-02-26 2000-09-08 Shionogi & Co., Ltd. Capsules molles a croquer presentant des proprietes d'administration ameliorees et leur procede de production
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
CA2461708C (en) * 2001-09-28 2012-08-07 Nutraceutix, Inc. Delivery system for biological component
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
TW200418525A (en) * 2002-11-20 2004-10-01 Akzo Nobel Nv Coated pharmaceutical tablets containing Tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
JP5207432B2 (ja) * 2003-04-29 2013-06-12 エム・エス・ディー・オス・ベー・フェー アンチ溶媒凝固プロセス
AU2004203420B8 (en) * 2003-05-23 2008-02-21 N.V. Organon Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
WO2005105278A2 (en) * 2004-05-05 2005-11-10 Akzo Nobel N.V. Antisolvent emulsion solidification process
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
WO2005120517A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
CN102085193B (zh) * 2009-12-08 2013-11-06 北京以岭生物工程技术有限公司 一种替勃龙口腔崩解片及其制备方法
CN104345098B (zh) * 2013-08-05 2016-04-13 华润紫竹药业有限公司 一种测定替勃龙片剂中抗氧剂含量的方法
WO2017191266A1 (en) 2016-05-04 2017-11-09 Mithra Pharmaceuticals S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
CH676470A5 (2) * 1988-02-03 1991-01-31 Nestle Sa
IE63051B1 (en) 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ZA941464B (en) 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
ES2185666T3 (es) 1993-09-03 2003-05-01 Smithkline Beecham Corp Formulacion estabilizada para comprimidos.
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation

Also Published As

Publication number Publication date
HK1023508A1 (en) 2000-09-15
US20040142028A1 (en) 2004-07-22
AU8014698A (en) 1998-11-13
HUP0001780A2 (hu) 2000-12-28
DK0975348T3 (da) 2005-03-07
AU742037B2 (en) 2001-12-13
ID22763A (id) 1999-12-09
DE69827484T2 (de) 2005-03-17
CN1494908A (zh) 2004-05-12
KR100580855B1 (ko) 2006-05-17
US20040142031A1 (en) 2004-07-22
TW570798B (en) 2004-01-11
RU2207133C2 (ru) 2003-06-27
US20010005513A1 (en) 2001-06-28
CA2288070A1 (en) 1998-10-29
NO995127D0 (no) 1999-10-21
PT975348E (pt) 2005-01-31
WO1998047517A1 (en) 1998-10-29
ES2232949T3 (es) 2005-06-01
CN1146424C (zh) 2004-04-21
NZ338028A (en) 2001-10-26
HUP0001780A3 (en) 2001-02-28
BR9809268A (pt) 2000-06-27
US6514958B1 (en) 2003-02-04
CN1253503A (zh) 2000-05-17
ATE281836T1 (de) 2004-11-15
TR199902530T2 (xx) 2000-05-22
US6399594B2 (en) 2002-06-04
EP0975348B1 (en) 2004-11-10
ZA983169B (en) 1998-10-20
US20040142030A1 (en) 2004-07-22
PL190227B1 (pl) 2005-11-30
DE69827484D1 (de) 2004-12-16
IL123984A (en) 2004-09-27
JPH10316573A (ja) 1998-12-02
US20030119801A1 (en) 2003-06-26
PL336658A1 (en) 2000-07-03
KR20010020163A (ko) 2001-03-15
EP0975348A1 (en) 2000-02-02
NO995127L (no) 1999-10-21

Similar Documents

Publication Publication Date Title
AR018891A1 (es) Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol
IL138767A0 (en) Anticancer compositions
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
ES2079743T3 (es) Tableta para chupar o masticar.
GR3006146T3 (2)
EA200101026A1 (ru) Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
FI972623A7 (fi) Progesteroniantagonisteina ja antiestrogeeneina vaikuttavia yhdisteitä käytettäväksi yhdessä naisilla raskaudenestoon
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
ES8503508A1 (es) Una forma de dosificacion unitaria farmaceutica
BRPI0512660A (pt) tablete carregável, e, método para a preparação de um tablete
ES2077897T3 (es) Preparados farmaceuticos secos de dosis bajas.
CO5540373A2 (es) Composicion farmaceutica de liberacion sostenida
US3755575A (en) Pharmaceutical compositions
BR0211198A (pt) Composições farmacêuticas e seu uso
BR9809268A (pt) Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
NO20083759L (no) Doserings aerosoler for administrering av farmasoytiske preparater
DE69602759D1 (de) Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
DE58906232D1 (de) Azelastin enthaltende Arzneimittel mit kontrollierter Wirkstoffabgabe.
FI962056A0 (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
ES2063412T3 (es) Tableta y granulado que contienen como principio activo mesna.
DE3783923D1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
KR920003963A (ko) 활성물질로서 이포스파미드를 함유하는 경구투여용 고체 제형

Legal Events

Date Code Title Description
FA Abandonment or withdrawal